FindTrial
Sign In

Glycated Albumin Versus HbA1c: Comparing Two Blood Tests for Monitoring Blood Sugar Control in Diabetes Mellitus.

Glycated Albumin versus HbA1c: a comparative evalution of glycemic assessment in Diabetes Mellitus. - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2026/06/111847
Enrollment
125
Registered
2026-06-03
Start date
Unknown
Completion date
Unknown
Last updated
2026-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E119- Type 2 diabetes mellitus without complications

Interventions

Intervention1: Nil: Nil Intervention2: Nil: Nil Control Intervention1: Nil: Nil

Sponsors

Datta Meghe Institute of Higher Education and Research
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Adults aged more than 30 years. 2. Diagnosed cases of diabetes mellitus. 3. Patients willing to give informed consent.

Exclusion criteria

Exclusion criteria: 1. Diabetes Mellitus. 2. Pregnant women. 3. Patients with hemoglobinopathies. 4. Patients with severe anemia, recent blood transfusion, or hemolytic anemia. 5. Patients with chronic liver disease or nephrotic syndrome affecting albumin levels.

Design outcomes

Primary

MeasureTime frame
Glycated albumin will show good correlation with HbA1c.Timepoint: Assessement will be within a 1 year—

Secondary

MeasureTime frame
GA may reflect short-term glycemic changes more accurately than HbA1c.Timepoint: Assessement will be within a 1 year—

Countries

India

Contacts

Public ContactDr Archana Dhok

Datta Meghe Institute Higher Education & Research

drarchanadhok@gmail.com7218271045

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Jun 29, 2026